Titre:
  • Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
Auteur:de Azambuja, Evandro; Agostinetto, Elisa; Procter, Marion; Eiger, Daniel; Pondé, Noam; Guillaume, Sébastien; Parlier, Damien; Lambertini, Matteo Md Phd M.; Desmet, Agnès; Caballero, Carmela; Aguila, Christian; Jerusalem, Guy; Walshe, Janice J.M.; Frank, Elizabeth E.S.; Bines, Jose; Loibl, Sibylle; Piccart-Gebhart, Martine; Ewer, M.; Dent, Susan; Plummer, Chris John C.; Suter, Thomas
Informations sur la publication:ESMO Open, 8, 1, 100772
Statut de publication:Publié, 2023-02-01
Sujet CREF:Généralités
Mots-clés:adjuvant
breast cancer
cardiotoxicity
HER2-positive
pertuzumab
trastuzumab
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2059-7029
info:doi/10.1016/j.esmoop.2022.100772
info:pii/S2059702922004069
info:scp/85146690760
info:pmid/36681013